An observational study in Patient Compliance, sponsored by Norwegian Medical Association. Completed at 2 sites in Norway. Per ClinicalTrials.gov, last updated 2012-04-24.
Sponsored by Norwegian Medical Association · Observational
The guidelines of The Norwegian authorities concerning the use of antibiotics in general practice state that for several common diseases such as pneumonia and tonsillitis, antibiotics should be given four times daily instead of three times daily. The study´s aim is to see whether the patient compliance is significantly reduced in antibiotic regimes of 3 or 4 daily doses as compared to 1 or 2 daily doses.
All patients given antibiotic tablets, independent of diagnosis and medicament, are included. All patients give a written consent. Within a week after the end of the treatment all patients are contacted by one of the authors and asked a few standardized questions concerning their compliance with the treatment.
133 studies on the registry are indexed under Patient Compliance; 42 are open to participants now.
This study's enrollment of 270 is above the median of 200 across 31 observational studies indexed under Patient Compliance.
Browse Patient Compliance studies →This is the only study on the registry with Norwegian Medical Association as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Patients in two different primary care clinics.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This study is completed, as verified in Apr 2012. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.